Stockholm 17:30
+0,30% Idag
+26,29% Sedan årsskifte
-0,01% OMXSPI

2018-12-14 15:40:11

New issue of CombiGene's newsletter Ingenious


Read CombiGene's newsletter Ingeneious in English

https://issuu.com/pub10/docs/ingeneious_5_2018?e=28526555/66403796


CombiGene AB (publ)

Jan Nilsson, VD
Tel: +46 (0)704 66 31 63
jan.nilsson@combigene.com


About CombiGene AB

CombiGene's business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen,

CombiGene has offices at Medicon Village in Lund, Sweden.
The company is public and listed on the Swedish marketplace Spotlight. www.combigene.com


Attached html: HTML
Attached pdf: PDF